PT2379114E - Conjugados compreendendo nanopartículas revestidas com compostos contendo platina - Google Patents

Conjugados compreendendo nanopartículas revestidas com compostos contendo platina Download PDF

Info

Publication number
PT2379114E
PT2379114E PT97683957T PT09768395T PT2379114E PT 2379114 E PT2379114 E PT 2379114E PT 97683957 T PT97683957 T PT 97683957T PT 09768395 T PT09768395 T PT 09768395T PT 2379114 E PT2379114 E PT 2379114E
Authority
PT
Portugal
Prior art keywords
conjugates
understanding
compounds containing
containing platinum
nanoparticles coated
Prior art date
Application number
PT97683957T
Other languages
English (en)
Portuguese (pt)
Inventor
Víctor Franco Puntes
Fernando Domínguez Puente
Francisco Manuel Romero Martínez
Óscar Gallego Rubio
Original Assignee
Univ Valencia
Institució Catalana De Recerca I Estudis Avançats
Fundació Privada Inst Catal De Nanotecnologia
Fundació Privada Inst De Recerca De L Hospital De La Santa Creu I Sant Pau
Univ Santiago Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Valencia, Institució Catalana De Recerca I Estudis Avançats, Fundació Privada Inst Catal De Nanotecnologia, Fundació Privada Inst De Recerca De L Hospital De La Santa Creu I Sant Pau, Univ Santiago Compostela filed Critical Univ Valencia
Publication of PT2379114E publication Critical patent/PT2379114E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Ceramic Engineering (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Powder Metallurgy (AREA)
PT97683957T 2008-12-16 2009-12-15 Conjugados compreendendo nanopartículas revestidas com compostos contendo platina PT2379114E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08171870 2008-12-16

Publications (1)

Publication Number Publication Date
PT2379114E true PT2379114E (pt) 2014-10-06

Family

ID=40568646

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97683957T PT2379114E (pt) 2008-12-16 2009-12-15 Conjugados compreendendo nanopartículas revestidas com compostos contendo platina

Country Status (13)

Country Link
US (1) US9023370B2 (enExample)
EP (1) EP2379114B1 (enExample)
JP (1) JP5873719B2 (enExample)
CA (1) CA2745972C (enExample)
CY (1) CY1115601T1 (enExample)
DK (1) DK2379114T3 (enExample)
ES (1) ES2505890T3 (enExample)
HR (1) HRP20140804T1 (enExample)
IL (1) IL213408A (enExample)
PL (1) PL2379114T3 (enExample)
PT (1) PT2379114E (enExample)
SI (1) SI2379114T1 (enExample)
WO (1) WO2010069941A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0909435D0 (en) * 2009-06-02 2009-07-15 Univ Strathclyde Nanoparticle for biomolecule delivery
ES2392528B1 (es) * 2010-12-28 2013-10-21 Endor Nanotechnologies, S.L. Sistema de liberación de agente terapéutico, composiciones farmacéuticas que lo contienen, su preparación y su uso médico.
ITRM20130138A1 (it) 2013-03-07 2014-09-08 Consiglio Nazionale Ricerche Assemblato comprendente un assorbitore della luce nel vicino infrarosso legato covalentemente ad un inibitore dell'anidrasi carbonica
JP6316011B2 (ja) * 2014-02-04 2018-04-25 国立大学法人滋賀医科大学 抗癌剤が担持されたナノ粒子
JP7018191B2 (ja) * 2016-01-29 2022-02-10 国立大学法人北海道大学 細胞内物質移送システムおよびその利用
PL236093B1 (pl) 2017-07-04 2020-11-30 Dominika Szczepaniak Rozpuszczalne w wodzie kompleksy złota (III), sposób wytwarzania rozpuszczalnych w wodzie kompleksów złota (III) i ich zastosowanie
EP3908324B1 (en) 2019-01-08 2022-05-11 Nanonica S.A. Conjugates comprising nanoparticles coated with platinum derivatives through sulfonyl or phosphonyl-containing linkers
TW202615847A (zh) * 2024-09-27 2026-04-16 高雄醫學大學 檢測dna甲基化的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR851932B (enExample) 1984-08-14 1985-12-13 Engelhard Corp
JP2866554B2 (ja) 1992-08-25 1999-03-08 松下電器産業株式会社 情報記録媒体とその製造方法及び情報記録媒体の使用方法
JP2005535604A (ja) 2002-06-03 2005-11-24 アルニス バイオサイエンシーズ, インコーポレイテッド 治療剤を含むポリマーナノ物品
WO2006037081A2 (en) * 2004-09-28 2006-04-06 The Regents Of The University Of California Nanoparticle radiosensitizers
US7601331B2 (en) * 2004-11-10 2009-10-13 National University Of Singapore NIR-sensitive nanoparticle
US20060222595A1 (en) * 2005-03-31 2006-10-05 Priyabrata Mukherjee Nanoparticles for therapeutic and diagnostic applications
US8785505B2 (en) * 2005-10-28 2014-07-22 The Regents Of The University Of California Toxicology and cellular effect of manufactured nanomaterials

Also Published As

Publication number Publication date
WO2010069941A1 (en) 2010-06-24
US20110262500A1 (en) 2011-10-27
CY1115601T1 (el) 2017-01-04
CA2745972A1 (en) 2010-06-24
IL213408A0 (en) 2011-07-31
HRP20140804T1 (hr) 2014-11-07
SI2379114T1 (sl) 2014-11-28
JP2012512149A (ja) 2012-05-31
IL213408A (en) 2017-06-29
US9023370B2 (en) 2015-05-05
EP2379114A1 (en) 2011-10-26
JP5873719B2 (ja) 2016-03-01
PL2379114T3 (pl) 2014-12-31
CA2745972C (en) 2016-11-01
ES2505890T3 (es) 2014-10-10
EP2379114B1 (en) 2014-07-09
DK2379114T3 (da) 2014-09-29

Similar Documents

Publication Publication Date Title
BRPI0911067A2 (pt) imunoensaios sensíveis usando nanopartículas revestidas
BRPI0921002A2 (pt) composição branqueadora com sílica fundida
BRPI0910515A2 (pt) composição líquida
BRPI0913515A2 (pt) fechamento com mecanismo limitador
EP2320221A4 (en) ELECTRODE
BRPI0919228A2 (pt) um inseridor
BRPI0913513A2 (pt) fechamento com mecanismo limitador
BRPI0921629A2 (pt) composição de revestimento anti-incrustação compreendendo nanopartículas
BRPI0908938A2 (pt) Pré-câmara
ATE535454T1 (de) Wiederbefüllbarer behälter
EP2284538A4 (en) Biosensor
BRPI0914098A2 (pt) biosensor
FR2933621B1 (fr) Sonde implantable
EP2280284A4 (en) Biosensor
ATE510152T1 (de) Verbesserte differenzialhalteringanordnung
DK2379114T3 (da) Konjugater omfattende nanopartikler overtrukket med platinholdige forbindelser
BRPI0821498A2 (pt) Estrutura de queimador
DK2252471T3 (da) Blyant
EP2346683A4 (en) SUSZEPTORENSTRUKTUR
EP2256162A4 (en) polyacetal resin
EP2382339A4 (en) AMINE-BASED LIGAND ELECTRODEPOSITION COMPOSITIONS
DK2254963T3 (da) Kerne-skal-flowforbedrer
BRPI0919924A2 (pt) artigo de vidro com resistência química melhorada
EP2299483A4 (en) RIGGED DOUBLE SERVO NANO BREED
DK2370553T3 (da) BRÆNDSTOFSAMMENSÆTNING indeholdende tetrahydroquinolin